- Visto: 103
Reporte
Radioterapia Intraoperatoria con electrones en el tratamiento conservador del cáncer de mama
Experiencia del Departamento de Oncología Radioterápica del Hospital Clínica Bíblica
Edición IV Setiembre - Diciembre 2016
Dr. Julio Argüello Méndez
Especialista en Oncología Radioterápica. Máster Internacional de Tecnologías Avanzadas aplicadas en Oncología Radioterápica, Instituto Madrileño de Oncología, Madrid, España.
Miembro del Colegio de Médicos y Cirujanos de Costa Rica.
Costa Rica.
Dr. Rolando Loría Ruíz
Especialista en Oncología Radioterápica. Máster en Aplicaciones Tecnológicas Avanzadas en Oncología Radioterápica, Universidad de Murcia, España.
Miembro del Colegio de Médicos y Cirujanos de Costa Rica.
Costa Rica.
Resumen
Objetivo: Describir la experiencia de la RIO en el Hospital Clínica Bíblica, San José, Costa Rica.
Materiales y Métodos: De mayo de 2012 a septiembre de 2014, se ha tratado a 57 pacientes en el Hospital Clínica Bíblica; con haz de electrones con radioterapia intraoperatoria después del tratamiento quirúrgico conservador para el cáncer de mama temprano o avanzado, con refuerzo o como un único tratamiento de radioterapia.
Resultados: La duración promedio de entrega de los tratamientos es de 69,4 segundos (rango: 30s a 128s).
Conclusiones: Un haz de electrones de radioterapia intraoperatoria en el tratamiento conservador del cáncer de mama podría ser considerado una opción adecuada para pacientes de bajo riesgo y algunos pacientes con riesgo intermedio bien seleccionados, o para disminuir el tiempo total del tratamiento en los casos de cáncer de mama tempranos, o como un refuerzo anticipado en estadios avanzados.
Abstract
Objective: Describe the experience of the IOR in the Clinica Biblica Hospital, San Jose, Costa Rica.
Materials and methods: From May 2012 to September 2014 it has treated 57 patients in the Clinica Biblica Hospital with electron beam intraoperative radiotherapy after breast conservative treatment for early or advanced breast cancer, as boost or as a single radiotherapy treatment.
Results: The average duration of delivery of the treatments is 69.4 seconds (rank: 30s to 128s).
Conclusions: The electron beam intraoperative radiotherapy in the conservative treatment of breast cancer could be considered a suitable option for low risk patients and some well-selected intermediate-risk patients, or for decrease the total time of treatment in cases of advanced cancer to use as a boost.
Bibliografía
Amato, B., Rispoli, C., Iannone, L., Testa, S., Compagna, R. & Rocco, N. (2012) “Surgical margins of resection for breast cancer: current evidence”. Minerva Chir. 67(5): 445-452.
Arriagada, R., Le, M.G., Rochard, F. & Contesso, G. (1996) “Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow- up data”. Institut Gustave-Roussy Breast Cancer Group, J. Clin. Oncol. 14(5): 1558-1564.
Ballard-Barbash, R., Potosky, A.L., Harlan, L.C., Nayfield, S.G. & Kessler, L.G. (1996) “Factors associated with surgical and radiation therapy for early stage breast cancer in older women”. J. Natl. Cancer Inst. 88: 716-726.
Clarke, M., Collins, R., Darby, S., Davies, C., Elphinstone, P. et al. (2005) “Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials”. Lancet. 366: 2087-2106.
Farrow, D.C., Hunt, W.C. & Samet, J.M. (1992) “Geographic variation in the treatment of localized breast cáncer”. N Engl. J. Med. 326: 1097-1101.
Fisher, B., Constantino, J., Redmond, C., Fisher, E., Margolese, R., Dimitrov, N. et al. (1993) “Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cáncer”. N Engl. J. Med. 328: 1581-1586.
Fisher, B., Redmond, C., Poisson, R., Margolese, R., Wolmark, N., Wickerham, L. et al. (1989) “Eight-year results of a randomized clinical trial comparing total mastec- tomy and lumpectomy with or without irradiation in the treatment of breast cáncer”. N Engl. J. Med. 320: 822-828.
Hiotis, K., Ye, W., Sposto, R. & Skinner, K.A. (2005). “Predictors of breast conservation therapy: size is not all that matters”. Cancer. 103: 892-899.
Jacobson, J.A., Danforth, D.N., Cowan, K.H., d’Angelo, T., Steinberg, S.M., Pierce, L. et al. (1995) “Ten-year results of a comparison of conservation with mastectomy in the tretmant of stage I and II breast cáncer”. N Engl. J. Med. 332(14): 907-911.
Kirova, Y.M., Campana, F., Savignoni, A., et al. (2009) “Institut Curie Breast Cancer Study Group. Breast-conserving treatment in the elderly long-term results of adju- vant hypofractionated and normofractionated radiotherapy”. Int. J. Radiat. Oncol. Biol. Phys. 75(1): 76-81.
Legorreta, A.P., Liu, X. & Parker, R.G. (2000) “Examining the use of breast-conserving treatment for women with breast cancer in a managed care environment”. Am. J. Clin. Oncol. 23: 438-441.
Ministerio de Salud. (2014) Memoria Institucional. Ministerios de Salud. San José.
Polgar, C., Van Limbergen, E., Potter, R., Kovacs, G., Polo, A. et al. (2010) “Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence”. Radiother. Oncol. 94: 264-273.
START Trialists' Group; Bentzen, S.M., Agrawal, R.K., Aird, E.G. et al. (2008) “The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial”. Lancet Oncol. 9(4): 331-341.
Smith, B.D., Arthur, D.W., Bucholz, T.A., Haffty, B.G., Hahn, C.A., et al. (2009) “Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO)”. Int. J. Radiat. Oncol. Biol. Phys. 74: 987-1001.
Van Dongen, J.A., Voogd, A.C., Fentiman, I.S., Legrand, C., Sylvester, R.J., Tong, D. et al. (2000) “Long-term results of a randomized trial comparing breast- conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial”. J. Natl. Cancer Inst. 92(14): 1143-1150.
Veronesi, U., Orecchia, R., Maisonneuve, P., et al. (2012) “Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial”. Lancet Oncol. 14(13):1269-1277.
Veronesi, U., Saccozzi, R., Del Vecchio M. et al. (1981). “Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast”. New. Engl. J. Med. 305: 6-11.
Vinh-Hung, V. & Verschraegen, C. (2004) “Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality”. J. Natl. Cancer Inst. 96: 115-121.
Whelan, T.J., Pignol, J.P., Levine, M.N. et al. (2010) “Long-term results of hypofractio- nated radiation therapy for breast cáncer”. N Engl. J. Med. 362(6): 513-520.
Esta obra está bajo una licencia internacional Creative Commons: Atribución-NoComercial-CompartirIgual 4.0 Internacional (CC BY-NC-SA 4.0)
Realizar búsqueda